AposHealth® (previously AposTherapy®) is a global leader in the identification and treatment of gait-related conditions.
The AposHealth®’s foot-worn “Apos3” device is FDA-cleared for treating knee osteoarthritis, to help temporarily reduce knee pain and improve lower extremity function during activities of daily living. It is also a non-FDA cleared wellness device which can help patients live well with other gait-related conditions such as chronic low back and hip pain.
With a mission to advance global health through the power of movement, AposHealth®’s latest business unit AposIQ, combines innovative technology, data science and over a decade of experience in gait modification to determine the optimal way to adjust patients’ gaits over time.
Since 2005, AposHealth® has been making it possible for patients in the US, UK, and Israel, to develop better movement patterns and get back to doing the things they love.
The AposHealth®’s foot-worn “Apos3” device is FDA-cleared for treating knee osteoarthritis, to help temporarily reduce knee pain and improve lower extremity function during activities of daily living. It is also a non-FDA cleared wellness device which can help patients live well with other gait-related conditions such as chronic low back and hip pain.
With a mission to advance global health through the power of movement, AposHealth®’s latest business unit AposIQ, combines innovative technology, data science and over a decade of experience in gait modification to determine the optimal way to adjust patients’ gaits over time.
Since 2005, AposHealth® has been making it possible for patients in the US, UK, and Israel, to develop better movement patterns and get back to doing the things they love.
Location: United States, New York
Employees: 51-200
Phone: +1 855-999-2767
Total raised: $11M
Founded date: 2004
Funding Rounds 1
| Date | Series | Amount | Investors |
| 17.02.2020 | Series A | $11M | aMoon Fund |
Mentions in press and media 5
| Date | Title | Description |
| 26.06.2025 | New Study Finds Breakthrough Knee & Back Pain Treatment Cuts Musculoskeletal Costs by 81% for Major Health Provider | Apos Treatment Program A large risk-bearing provider in NJ cut MSK costs by 81%, saving $9M in 20 months, using Apos®—a non-invasive, foot-worn device for chronic knee & back pain. NEW YORK, NY, UNITED STATES, June 26, 2025 /EINPresswir... |
| 23.01.2025 | New Study Finds Apos® Superior to Traditional Physical Therapy for Chronic Low Back Pain | Apos Treatment Program New Study Finds Apos® Superior to Traditional Physical Therapy for Chronic Low Back Pain NEW YORK, NY, UNITED STATES, January 23, 2025 /EINPresswire.com/ -- A new study published in the Global Spine Journal, one of th... |
| 08.01.2025 | AposHealth® Wins 2025 Global Recognition Award for Revolutionary Musculoskeletal Care Innovation | Apos Treatment Program AposHealth wins the 2025 Global Recognition Award for revolutionizing musculoskeletal care with Apos®, a drug-free, patient-centric solution for chronic pain NEW YORK, NY, UNITED STATES, January 8, 2025 /EINPresswire.... |
| 12.12.2024 | AposHealth Wins 2024 Global Excellence Award for Best Knee-Pain Relief Device | Apos Treatment Program AposHealth received the 2024 Global Excellence Award for its innovative, non-surgical knee-pain relief solution, Apos®, which transforms lives and reduces costs NEW YORK, NY, UNITED STATES, December 12, 2024 /EINPress... |
| 04.06.2024 | Apos® Demonstrates 43% Reduction in Healthcare Utilization and Costs for Patients with Knee and Back Pain | New study shows Apos® treatment reduces healthcare costs by 43% for knee OA & low back pain patients. NEW YORK, NEW YORK, UNITED STATES, June 4, 2024 /EINPresswire.com/ -- A recent study published in the Journal of Healthcare Economics ... |